Peptides were synthesized using a PS3 automated peptide synthesizer (Protein Technologies, Phoenix, AZ) via standard Fmoc/tbu solid-phase peptide synthesis unless noted in Table 1. Manual coupling of amino acids was performed by incubating the peptide resin in a solution of amino acid (4 eq.) and HCTU (3.9 eq.) in 0.4 M N-methylmorpholine in DMF for 3 h. Fmoc deprotection was performed by two 30-min incubations in 20% (v/v) piperidine in DMF. Biotinylated resin was prepared from NovaPEG rink amide resin as reported previously27 (link) and was used for the synthesis of all biotinylated peptides. Peptides were cleaved off the resin by incubating in a cleavage cocktail containing TFA/DMB/TIPS/EDT (90:5:2.5:2.5 v/v/v/v) for 2.5 h followed by double precipitation in cold ether. EDT was included in the cleavage cocktail only for peptides containing a free cysteine after cleavage. The crude peptides were purified by RP-HPLC (Agilent 1200, Santa Clara, CA) to 95% purity using a Phenomenex Fusion-RP C18 semi-preparative column (Torrance, CA) at the flow rate of 5 mL/min with H2O (0.1% TFA) and ACN (0.1% TFA) as a mobile phase. Molecular weights of the purified peptides were confirmed by MALDI-ToF Mass Spectrometry (MS).